Synthesis of 5,6-Dihydro-4-hydroxy-2- pyrones as HIV-1 Protease Inhibitors: The Profound Effect of Polarity on Antiviral Activity
Susan E. Hagen(Pfizer (United States)), Steven VanderRoest(Pfizer (United States)), Harriet W. Hamilton(Pfizer (United States)), Larry J. Markoski(Pfizer (United States)), Christopher Gajda(Pfizer (United States)), Elizabeth A. Lunney(Pfizer (United States)), Edmund L. Ellsworth(Pfizer (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), James M. Saunders(Pfizer (United States)), Carolyn Nouhan(Pfizer (United States)), Donna Ferguson(Pfizer (United States)), Donald Hupe(Pfizer (United States)), J. V. N. Vara Prasad(Pfizer (United States)), F Boyer(Pfizer (United States)), Bradley D. Tait(Pfizer (United States)), Stephen J. Gracheck(Pfizer (United States)), John M. Domagala(Pfizer (United States)), Bruce A. Steinbaugh(Pfizer (United States))
Cited by 62
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
|Biochemistry|2008|550